Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386886257> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4386886257 abstract "<h3>Background</h3> Liver stiffness measurements (LSM) have been determined to be one of the best markers for detection of advanced fibrosis or cirrhosis in primary biliary cholangitis (PBC).<sup>1</sup> LSM of 9.6kPa or greater is associated with a 5-fold increase in the risk of liver decompensation, liver transplantation, and death.<sup>1</sup> The 5 year open-label extension of the POISE trial demonstrated that non-invasive markers of liver fibrosis stabilised with obeticholic acid (OCA) treatment.<sup>2</sup> This is important as worsening LSM is associated with a poor prognosis.<sup>1</sup> <h3>Method</h3> Between November 2017 and December 2021, 169 patients were referred to the King’s PBC MDM for consideration of second line therapies. 87 patients were recommended to start OCA. Baseline and follow up Fibroscan data after 1 year of OCA treatment was collected for each patient and assessed alongside ALP levels. <h3>Results</h3> 69 (79%) patients had baseline Fibroscan results available. 40 patients were still on OCA and under the King’s PBC MDM at month 12. Of these, 25 patients had follow up Fibroscans available. 7/25 (28%) patients demonstrated a stable LSM whereby the change in LSM was less than 20% from baseline (p=0.7344). 11/25 (44%) patients saw an improvement in LSM (20% or greater decrease in LSM from baseline) after at least 12 months of OCA which was statistically significant (p = 0.001). 10 of these patients had achieved the maximum dose of OCA 10mg once daily. 1 of these patients demonstrated an improvement in LSM despite an increase in ALP at 1 year. 7/25 (28%) patients saw a worsening of LSM (20% or greater increase in LSM from baseline). (p=0.0156) Despite seeing a biochemical response (ALP <1.67xULN), 2 patients demonstrated a worsening LSM. Median LSM at follow up was 8kPa (range: 2.8–28.3kPa). <h3>Discussion</h3> Local data showed that 72% of patients demonstrated a stable or improved LSM after 1 year or more of OCA therapy. 37.5% of patients prescribed OCA did not have follow-up LSM data available. Currently, national and international guidelines make no recommendation on how often transient elastography should be performed in PBC. Follow up Fibroscans were completed more frequently for patients monitored at KCH than patients under local follow up at referring sites. This could be due to the availability of transient elastography at referring sites. ELF scores could be used to monitor fibrosis, as demonstrated in the POISE trial.<sup>2</sup> This project highlights the need for standardised fibrosis monitoring across our network. <h3>References</h3> Hirschfield GM, Beuers U, Corpechot C, <i>et al.</i> EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. <i>Journal of Hepatology</i> 2017;<b>67</b>:145–72. doi:10.1016/j.jhep.2017.03.022 Nevens, <i>et al.</i> 2019. Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis. <i>Digestive and Liver Disease</i> 2020;<b>1</b>:e30. Doi: 10.1016/j.dld.2019.12.114" @default.
- W4386886257 created "2023-09-21" @default.
- W4386886257 creator A5002032514 @default.
- W4386886257 creator A5013018249 @default.
- W4386886257 creator A5032155696 @default.
- W4386886257 creator A5033296166 @default.
- W4386886257 creator A5038647808 @default.
- W4386886257 date "2023-09-01" @default.
- W4386886257 modified "2023-09-29" @default.
- W4386886257 title "P103 Does treatment with obeticholic acid result in improvement or stabilisation of non-invasive fibrosis scores in PBC?" @default.
- W4386886257 doi "https://doi.org/10.1136/gutjnl-2023-basl.118" @default.
- W4386886257 hasPublicationYear "2023" @default.
- W4386886257 type Work @default.
- W4386886257 citedByCount "0" @default.
- W4386886257 crossrefType "proceedings-article" @default.
- W4386886257 hasAuthorship W4386886257A5002032514 @default.
- W4386886257 hasAuthorship W4386886257A5013018249 @default.
- W4386886257 hasAuthorship W4386886257A5032155696 @default.
- W4386886257 hasAuthorship W4386886257A5033296166 @default.
- W4386886257 hasAuthorship W4386886257A5038647808 @default.
- W4386886257 hasConcept C126322002 @default.
- W4386886257 hasConcept C170493617 @default.
- W4386886257 hasConcept C2777067796 @default.
- W4386886257 hasConcept C2777214474 @default.
- W4386886257 hasConcept C2778721985 @default.
- W4386886257 hasConcept C2778938600 @default.
- W4386886257 hasConcept C2779609443 @default.
- W4386886257 hasConcept C2780559512 @default.
- W4386886257 hasConcept C2911091166 @default.
- W4386886257 hasConcept C71924100 @default.
- W4386886257 hasConcept C90924648 @default.
- W4386886257 hasConceptScore W4386886257C126322002 @default.
- W4386886257 hasConceptScore W4386886257C170493617 @default.
- W4386886257 hasConceptScore W4386886257C2777067796 @default.
- W4386886257 hasConceptScore W4386886257C2777214474 @default.
- W4386886257 hasConceptScore W4386886257C2778721985 @default.
- W4386886257 hasConceptScore W4386886257C2778938600 @default.
- W4386886257 hasConceptScore W4386886257C2779609443 @default.
- W4386886257 hasConceptScore W4386886257C2780559512 @default.
- W4386886257 hasConceptScore W4386886257C2911091166 @default.
- W4386886257 hasConceptScore W4386886257C71924100 @default.
- W4386886257 hasConceptScore W4386886257C90924648 @default.
- W4386886257 hasLocation W43868862571 @default.
- W4386886257 hasOpenAccess W4386886257 @default.
- W4386886257 hasPrimaryLocation W43868862571 @default.
- W4386886257 hasRelatedWork W1943649358 @default.
- W4386886257 hasRelatedWork W1976488520 @default.
- W4386886257 hasRelatedWork W1984970689 @default.
- W4386886257 hasRelatedWork W2130930859 @default.
- W4386886257 hasRelatedWork W2154690931 @default.
- W4386886257 hasRelatedWork W2161019027 @default.
- W4386886257 hasRelatedWork W2376727204 @default.
- W4386886257 hasRelatedWork W2392142658 @default.
- W4386886257 hasRelatedWork W3032508731 @default.
- W4386886257 hasRelatedWork W3158422692 @default.
- W4386886257 isParatext "false" @default.
- W4386886257 isRetracted "false" @default.
- W4386886257 workType "article" @default.